CRP and COVID-19: Collectively, these results reveal that the increase of hyaluronan is significantly relevant to the reduction of lymphocytes and the upregulation of CRP, D-dimer, and fibrinogen in COVID-19 patients, suggesting hyaluronan may play a key role during the clinical progression of COVID-19.